SCHEMBL7862795

SCHEMBL7862795

CCNC(=O)c1ccc(S(=O)(=O)NC(=O)c2ccc(OC(=O)NC(=O)CN)nc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
EGFR P00533 3/20 0.44
P4HTM Q9NXG6 4/20 0.41
OPRM1 P35372 1/20 0.39
OPRD1 P41143 1/20 0.39
OPRK1 P41145 1/20 0.39
BCL2L1 Q07817 1/20 0.38
MCL1 Q07820 1/20 0.38
CA12 O43570 1/20 0.38
CA9 Q16790 1/20 0.38
EPHX2 P34913 1/20 0.38
FLT1 P17948 1/20 0.38
FLT4 P35916 1/20 0.38
KDR P35968 1/20 0.38
GABRA5 P31644 1/20 0.37
CA2 P00918 2/20 0.37
PTGS2 P35354 3/20 0.37
CA1 P00915 1/20 0.37
GABRA1 P14867 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7870341 0.91 CA2 (0.43) EGFRP4HTMBCL2L1MCL1CA2
SCHEMBL7871727 0.90 CA2 (0.44) EGFRP4HTMEPHX2GABRA5CA2
SCHEMBL7869451 0.89 CA2 (0.49) EGFRP4HTMCA2
SCHEMBL7871629 0.89 CA2 (0.46) EGFRP4HTMEPHX2CA2
SCHEMBL7869130 0.88 KMT2A (0.44) EGFRP4HTMCA2
SCHEMBL7862735 0.87 P4HTM (0.56) EGFRP4HTMBCL2L1MCL1PTGS2
SCHEMBL7870554 0.86 NPC1 (0.49) P4HTMBCL2L1MCL1CA12CA9
SCHEMBL7867814 0.85 MEN1 (0.48) P4HTMBCL2L1MCL1CA12CA9
SCHEMBL7867675 0.85 NPC1 (0.49) P4HTMBCL2L1MCL1CA2
SCHEMBL7871673 0.85 ACACB (0.43) EGFRP4HTMCA12CA9CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0562512-B1 Sulfonamidocarbonylpyridine-2-carboxamides and their use as medicines HOECHST AG (DE) 2001-02-21 EP disclosed
EP-0562512-A1 Sulfonamido- and sulfonamidocarbonyl-pyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation and their use as medicines HOECHST AKTIENGESELLSCHAFT (DE) 1993-09-29 EP disclosed